Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Psoriatic arthritis Stories

2013-06-12 08:29:17

THOUSAND OAKS, Calif. and GAITHERSBURG, Md., June 12, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca (AZN), with its biologics research and development arm MedImmune, today announced that they will present data from a Phase 2 study evaluating brodalumab, a human monoclonal antibody targeting the IL-17 receptor, being investigated for the treatment of psoriatic arthritis at the 2013 European League Against Rheumatism (EULAR) Annual Meeting in Madrid, June 12-15, 2013. "The...

2013-06-06 08:30:50

Arthritis Foundation Hosts 2013 National Juvenile Arthritis Conference in Anaheim, Calif., on July 18-21 LOS ANGELES, June 6, 2013 /PRNewswire-USNewswire/ -- Fifteen-year-old Caitlin looks and acts like a typical high school sophomore. One would never guess that both of her hips were replaced by the age of 12 as a result of systemic juvenile idiopathic arthritis. Nearly 300,000 children like Caitlin are affected by juvenile arthritis (JA), an umbrella term used to describe the...

2013-06-04 08:30:23

PORTLAND, Ore., June 4, 2013 /PRNewswire-USNewswire/ -- Six of the top scientists studying psoriasis--the most common autoimmune disease in the country, affecting 7.5 million Americans--and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases. (Photo:...

2013-06-03 08:25:49

Efficacy Advantages of TNF-Alpha Inhibitors Will Likely Constrain Uptake of Emerging Therapies, According to a New Report from Decision Resources BURLINGTON, Mass., June 3, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that based on clinical data and the opinions of interviewed thought leaders, AbbVie/Eisai's Humira has the strongest clinical profile among key marketed products that...

2013-05-07 23:03:48

World Autoimmune Arthritis Day 2013 (#WAAD13) is a ground-breaking, annual 47-hour Virtual Convention that will unite 36 nonprofits and dozens of advocates and experts from around the world in order to provide educational and awareness information to patients, their supporters, and the general public. (PRWEB) May 07, 2013 This year may only be the second annual WAAD Virtual Convention, but the International Autoimmune Arthritis Movement (501c3 Nonprofit Hosts of #WAAD13) estimates over...

2013-05-02 12:26:43

Report Shows Low or No Walking Among Those Who Could Benefit the Most ATLANTA, May 2, 2013 /PRNewswire-USNewswire/ -- Walking is a proven way to keep joints healthy and relieve arthritis pain, but not many people are taking advantage of this recommended activity or community-based programs that can help, says the Arthritis Foundation in response to a government report released today in conjunction with Arthritis Month in May. According to the Centers for Disease Control and Prevention...

2013-03-19 08:27:07

BALLERUP, Denmark, March 19, 2013 /PRNewswire/ -- LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation (NPF) in the United States that puts patients at the heart of LEO Pharma's innovation process. The move supports the dermatology company's aim to develop future care solutions that address patients' real-life needs. The co-creation agreement with the US National Psoriasis Foundation aims to ensure that the needs of people suffering from...

2013-03-11 12:24:56

Americans Join Together to Fight Nation's Leading Cause of Disability ATLANTA, March 11, 2013 /PRNewswire/ -- The 2013 Arthritis Walk, the Arthritis Foundation's annual nationwide event that raises awareness and funds to fight arthritis, officially kicked-off this month and will take place in nearly 130 cities through November this year. Arthritis Walk unites communities across the country to put an end to arthritis, a chronic disease that affects 50 million adults and 300,000...

2013-02-27 12:26:08

Survey finds that this common ailment has a big impact on quality of life ROCKLIN, Calif., Feb. 27, 2013 /PRNewswire-USNewswire/ -- Most people expect some aches and pains due to arthritis as they age, but a new survey by the American Chronic Pain Association (ACPA) finds that many with arthritis face significant disability due to the condition. In addition, those with arthritis live with fears about the course of their condition. In combination, these factors erode quality of life....

2013-02-20 08:27:57

ATLANTA, Feb. 20, 2013 /PRNewswire/ -- UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia(®) (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA). The regulatory filings for two new indications for certolizumab pegol are now under review by the US...